EBRIBAFUSP ALFA
UNII FR7T6AM49L

Substance Identification & Data

This profile provides standardized clinical and technical data for Ebribafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FR7T6AM49L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2839652-75-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FR7T6AM49L

CAS Registry Number

2839652-75-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EBRIBAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C207027

National Cancer Institute reference terminology for clinical and research data.

INN ID

12890

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-34

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ebribafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EBRIBAFUSP ALFA

Common Names & Synonyms

EBRIBAFUSP ALFA [INN]

EBRIBAFUSP ALFA [USAN]

GAMMA 4 HEAVY CHAIN (1-437) (VH (HOMO SAPIENS IGHV1-46*01 -(IGHD) -IGHJ4*01, CDR-KABAT (5.17.2) (31-35.50-66.99-100)) (1-111) -HOMO SAPIENS IGHG4*01 (CH1 (112-209), HINGE S 219>P (210-221), CH2 L 226>E(222-331), CH3 M 419>L, N 425>S (332-436), CHS K 438>DEL (437)) (112-437))FUSED VIA A (G4S) 2 PEPTIDE LINKER (438-447) TO HUMAN COMPLEMENT FACTOR H FRAGMENT 1-305 (448-752 IN THE CURRENT SEQUENCE, CONTAINING THE FIRST FIVE CONSENSUS REPEAT SUSHI DOMAINS, RESIDUES 1_304, PLUS THE ADJACENT K 305),(125-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (HOMO SAPIENS IGKV2-30*01 -IGKJ4*01, CDR-KABAT (16.7.9) (24'-39'.55'-61'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (113'-219')); DIMER (217-217'':220-220'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-M, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (219-PROLINE,226-GLUTAMIC ACID,419-LEUCINE,425-SERINE,DE-438-LYSINE), ANTI-(HUMAN COMPLEMENT C3D) (HUMAN-MUS MUSCULUS MONOCLONAL ADX-097 .GAMMA.4-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER ((GGGGS)2) FUSION PROTEIN WITH 19-323-COMPLEMENT FACTOR H (HUMAN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ADX-097 .KAPPA.-CHAIN, DIMER

Technical Codes

ADX-097

External Clinical & Regulatory Resources

Previous UNIIFR7J081T20

Next UNIIFR7V2WM52Z